Articles

A new report looking at hypertension during two time periods 10 years apart has found that more US adults have high blood pressure than ever before. The prevalence has increased from almost 25% during the first period surveyed (1988–1994) to 28.9% during the second period (1999–2004).

The findings, provide further proof that inflammation plays a key role in the development of Type 1 diabetes and suggest that the protein – known as AAT –might be an option for clinical testing in humans.

New evidence discovered by researchers, shows that patients with Type 2 diabetes may be at increased risk of contracting tuberculosis because of a compromised immune system, resulting in life-threatening lung infections that are more difficult to treat.

Drinking moderate amounts of alcohol may protect women from developing type 2 diabetes but the effect of alcohol on inflammation and blood vessel function doesn’t appear to explain the relationship, new research suggests.

The genotyping work identified two new gene locations associated with type 1 diabetes.

Vision loss is nearly twice as common among U.S. adults with diabetes as those without diabetes and people with diabetes also have increased rates of glaucoma and cataracts, both of which can lead to vision loss.

Although the likelihood of having diabetes diagnosed is increased around the time Parkinson’s disease is identified, diabetes does not appear to increase the risk of Parkinson’s disease, according to new findings.

Impaired insulin response in midlife is associated with an increased risk of developing Alzheimer’s disease (AD) up to 35 years later, Swedish researchers report.

Two new articles examine the theory of “fetal programming” and their effect on racial health disparities. The studies, suggest that the higher rates of hypertension and cardiovascular disease present in African Americans may be a consequence of low birth weights, and that these low birth weights may be a result …

The Canadian government has decided to add bisphenol A to the country’s list of toxic substances, a move that is likely to renew attention on the widespread use of the controversial chemical linked to diabetes, liver and heart disease.